Home-Based Tele-Rehabilitation for Respiratory Function in Children With Duchenne Muscular Dystrophy
Condition(s) studied
Investigational drug(s) / intervention(s)
Home-Based Respiratory Telerehabilitation Program: A 6-week caregiver-assisted home-based respiratory telerehabilitation program for children with Duchenne muscular dystrophy. The program includes weekly remote education sessions, respiratory muscle exercises, airway clearance training, relaxation positioning, and self-directed home exercises performed at least 5 times per week. Outcomes are assessed before and after the intervention and at 2-week follow-up.
Study summary
This study evaluates the feasibility and preliminary clinical effects of a home-based tele-rehabilitation program aimed at improving respiratory function in children with Duchenne Muscular Dystrophy (DMD).
Eligibility
Primary outcome measure(s)
- Feasibility of the Home-Based Respiratory Tele-rehabilitation Program — Baseline to immediately after the 6-week intervention
Feasibility of the home-based respiratory telerehabilitation program will be assessed using exercise adherence rate, session attendance rate, and exercise log completion during the 6-week intervention period. These measures will be summarized descriptively as indicators of program feasibility. Higher percentages indicate better feasibility. - Acceptability of the Home-Based Respiratory Tele-rehabilitation Program — Immediately after the 6-week intervention and at 2-week follow-up
Acceptability of the home-based respiratory telerehabilitation program will be assessed using caregiver-reported satisfaction, perceived exercise difficulty, caregiver burden, and child participation questionnaires during the intervention period. Higher satisfaction and participation scores indicate greater acceptability, whereas higher perceived difficulty and caregiver burden scores indicate lower acceptability.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Samsung Medical Center | Seoul | Seoul |
More Samsung Medical Center trials in South Korea
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07629284 on ClinicalTrials.gov ↗ ← All trials in South Korea